Development of Islet Antigen 2 (IA2) Antibodies Post-COVID-19 Infection: A Sign of Autoimmunity or Latent Autoimmune Diabetes Mellitus in Adults (LADA)?

Authors

Nick Lee, Nova Southeastern UniversityFollow
Praveen Prabhu, Nova Southeastern UniversityFollow
Samyukta Swaminath, Nova Southeastern UniversityFollow
Sahar S. Amini, Nova Southeastern University

Document Type

Article

Publication Date

6-26-2023

Publication Title

Cureus

Keywords

gad 65, diabetes mellitus type 1.5, diabetes mellitus type 2, latent autoimmune diabetes in adults (lada), covid-19

ISSN

2168-8184

Volume

15

Issue/No.

6

First Page

e40971

Abstract

Further antibody tests and laboratory studies showed that the patient met the criteria for latent autoimmune diabetes in adults (LADA). In this case report, we will review the diagnostic workup and management of LADA in an individual following his COVID-19 infection.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

NSUWorks Citation

Lee, Nick; Prabhu, Praveen; Swaminath, Samyukta; and Amini, Sahar S., "Development of Islet Antigen 2 (IA2) Antibodies Post-COVID-19 Infection: A Sign of Autoimmunity or Latent Autoimmune Diabetes Mellitus in Adults (LADA)?" (2023). HPD Articles. 342.
https://nsuworks.nova.edu/hpd_facarticles/342

DOI

10.7759/cureus.40971

Copyright

© Copyright 2023 Lee et al.